Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
, 13 (1), 3-17

Attenuated Psychotic Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Meta-Analysis


Attenuated Psychotic Symptom Interventions in Youth at Risk of Psychosis: A Systematic Review and Meta-Analysis

Daniel J Devoe et al. Early Interv Psychiatry.


Aim: Attenuated psychotic symptoms (APSs) have been the primary emphasis in youth at clinical high risk (CHR) for psychosis for assessing symptomology and determining subsequent transition to a psychotic disorder. Previous reviews primarily focused on the efficacy of cognitive behavioural therapy (CBT) on APS; however, a comprehensive assessment of other interventions to date is lacking. Therefore, we conducted a systematic review and meta-analysis of all intervention studies examining APS in CHR youth.

Method: The authors searched Embase, CINAHL, PsycINFO, Medline and EBM from inception to May 2017. Studies were selected if they included any intervention that reported follow-up APS in youth at CHR. Interventions were evaluated and stratified by time using both pairwise and network meta-analyses (NMAs). Due to the differences in APS scales, effect sizes were calculated as Hedges g and reported as the standardized mean difference (SMD).

Results: Forty-one studies met our inclusion criteria. In pairwise meta-analyses, CBT was associated with a trend towards reduction in APS compared to controls at 12-months. In the NMA, integrated psychological therapy, CBT, supportive therapy, family therapy, needs-based interventions, omega-3, risperidone plus CBT and olanzapine were not significantly more effective at reducing APS at 6 and 12 months relative to any other intervention.

Conclusions: CBT demonstrated a slight trend at reducing APS at long-term follow-up compared to controls. No interventions were significantly more effective at reducing APS compared to all other interventions in the NMA. [Correction added on 4 June 2018, after first online publication: Some parts of the Abstract section particularly 'Results' and 'Conclusions' have been corrected.].

Keywords: clinical high risk; meta-analysis; schizophrenia; systematic review.

Similar articles

Cited by 10 PubMed Central articles


    1. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophrenia Research (of Publication: January 2011) 2011;125(121):154–161. - PubMed
    1. Addington J, Liu L, Perkins DO, Carrion RE, Keefe RSE, Woods SW. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms. Schizophrenia Bulletin. 2017;43(1):57–63. doi: 10.1093/schbul/sbw152. - DOI - PMC - PubMed
    1. Albert N, Glenthøj LB, Melau M, Jensen H, Hjorthøj C, Nordentoft M. Course of illness in a sample of patients diagnosed with a schizotypal disorder and treated in a specialized early intervention setting. Findings from the 3.5 year follow-up of the OPUS II study. Schizophrenia Research. 2016;182:24–30. doi: 10.1016/j.schres.2016.10.013. - DOI - PubMed
    1. Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan MSM, … Berger GE. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Archives of General Psychiatry (of Publication: February 2010) 2010;67(62):146–154. - PubMed
    1. Andreasen NC. Scale for the assessment of positive symptoms. Group. 1984;17(2):173–180.

Publication types

MeSH terms